Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride (SEATTLE)

This study has been completed.
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Acucela Inc. Identifier:
First received: February 28, 2013
Last updated: May 31, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)